|Número de publicación||US20050283148 A1|
|Tipo de publicación||Solicitud|
|Número de solicitud||US 10/870,202|
|Fecha de publicación||22 Dic 2005|
|Fecha de presentación||17 Jun 2004|
|Fecha de prioridad||17 Jun 2004|
|También publicado como||CA2570911A1, CN1981256A, EP1769320A2, US20070060921, US20070167943, US20100114095, US20130046292, WO2006009705A2, WO2006009705A3|
|Número de publicación||10870202, 870202, US 2005/0283148 A1, US 2005/283148 A1, US 20050283148 A1, US 20050283148A1, US 2005283148 A1, US 2005283148A1, US-A1-20050283148, US-A1-2005283148, US2005/0283148A1, US2005/283148A1, US20050283148 A1, US20050283148A1, US2005283148 A1, US2005283148A1|
|Inventores||William Janssen, James Newman, James Jones, Jeffrey Buske|
|Cesionario original||Janssen William M, Newman James P, Jones James W, Buske Jeffrey M|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (75), Citada por (58), Clasificaciones (15), Eventos legales (3)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
The present invention relates to a method and device used in the field of Minimally Invasive Surgery (or MIS) for interrupting the flow of signals through nerves. These nerves may be rendered incapable of transmitting signals either on a temporarily (hours, days or weeks) or a permanent (months or years) basis. This new device itself consists of a single puncture system, which incorporates both an active and return electrode capable of creating areas of nerve destruction, inhibition and ablation; a generator for precisely delivering RF energy, and the method necessary for properly locating the active tip and generating energy to ablate target nerves.
The human nervous system is used to send and receive signals. The pathway taken by the nerve signals convey sensory information such as pain, heat, cold and touch and command signals which cause movement (e.g. muscle contractions).
Often extraneous, undesired, or abnormal signals are generated (or are transmitted). Examples include (but are not limited to) the pinching of a minor nerve in the back, which causes extreme back pain, or the compression (or otherwise activation) of nerves causing referred pain. Also with certain diseases the lining of the nerves is compromised, or signals are spontaneously generated, which can cause a variety of maladies, from seizures to pain or (in extreme conditions) even death. Abnormal signal activations can cause many other problems including (but not limited to) twitching, tics, seizures, distortions, cramps, disabilities (in addition to pain), other undesirable conditions, or other painful, abnormal, undesirable, socially or physically detrimental afflictions. This device can be used to treat various types of nerve conditions. Such as functional applications to innervations of the posterior neck muscles that will relieve headaches, muscle strain, and pain. The device can be used to treat abnormal muscle activity a result of over stimulation of peripheral nerves, for relief of pain, spasticity, and dystonias. Further, conditions such as hyperhidrosis, rhinorrhea, drooling, and facial flushing, caused by the overactive signals from sympathetic and parasymapathetic nerve path ways, can be treated.
In other situations, the normal conduction of nerve signals can cause undesirable effects. For example in cosmetic applications the activation of the corrugator supercilli muscle causes frown lines which may result in permanent distortion of the brow (or forehead); giving the appearance of premature aging. By interruption of the corrugator supercilli activation nerves, this phenomenon may be terminated. Other cosmetic applications include all neck and facial expression muscles, which are innervated by cranial nerves (including, but not limited to, the orbicularis oculi, orbicularis ori, frontalis, procerus, temporalis, masseter, zygomaticus major, depressor anguli oris, depressor labii inferioris, mentalis, platysma, and/or corrugator supercili muscles). Further, Platysma myoides, Procerus muscles, back muscles, back pain, and other pain/abnormal muscle or nerve activations would be treatable.
This technology describes an improved method of interrupting signal flows through nerve fibers with a new single puncture technique; used in the emerging field of Minimally Invasive Surgery (or MIS). Interrupting such flows is done using electricity to form an electrical circuit with the nerve. The circuit created is formed with a source of energy connected to an active electrode with a return path again connected to the source.
Traditional electrosurgical procedures use either a unipolar or bipolar device connected to that energy source. A unipolar electrode system includes a small surface area electrode, and a return electrode. The return electrode is generally larger in size, and is either resistively or capacitively coupled to the body. Since the same amount of current must flow through each electrode to complete the circuit; the heat generated in the return electrode is dissipated over a larger surface area, and whenever possible, the return electrode is located in areas of high blood flow (such as the biceps, buttocks or other muscular or highly vascularized area) so that heat generated is rapidly carried away, thus preventing a heat rise and consequent burns of the tissue. The advantage of these system is the ability to place the unipolar probe exactly where it is needed and optimally focus the energy where desired. The disadvantage of the system is that the return electrode must be properly placed and in contact throughout the procedure. A resistive return electrode would typically be coated with a conductive paste or jelly. If the contact with the patient is reduced or if the jelly dries out, a high-current density area would result, increasing the probability for burns at the contact point.
Bipolar electrode systems use a two surface device (such as forceps, tweezers, pliers and other grasping type instruments) where two separate surfaces can be brought together mechanically under force. Each opposing surface is connected to one of the two source connections of the electrical generator. Then the desired object is held and compressed between the two surfaces. Then when the electrical energy is applied, it is concentrated (and focused) so that tissue can be cut, desiccated, burned, killed, stunned, closed, destroyed or sealed between the grasping surfaces. Assuming the instrument has been designed and used properly, the resulting current flow will be constrained within the target tissue between the two surfaces. The disadvantage of the conventional bipolar system is that the target tissue must be properly located and isolated between these surfaces. To reduce extraneous current flow the electrodes can not make contact with other tissue, which often requires visual guidance (such as direct visualization, use of a scope, ultrasound or other direct visualization methods) so that the target tissue is properly contained within the bipolar electrodes themselves, prior to application of electrical energy.
In recent years, considerable efforts have been made in refining sources of RF or electrical energy, as well as devices for applying electrical energy to specific targeted tissue. Various applications such as tachyarrhythmia ablation have been developed, whereby accessory (extra) pathways within the heart conduct electrical energy in an abnormal pattern. This abnormal signal flow results in excessive, and potentially lethal cardiac arrhythmias. RF ablation (as it is called) delivers electrical energy in either a bipolar or unipolar configuration utilizing a long catheter, similar to an EP (electrophysiology) catheter. That catheter (consisting of a long system of wires and supporting structures normally introduced via an artery or vein which leads into the heart) is manipulated using various guidance techniques, such as measurement of electrical activity, ultrasonic guidance, and/or X-ray visualization, into the target area. Electrical energy is then applied and the target tissue is destroyed.
A wide variety of technology in the development of related systems, devices and EP products has already been disclosed. For example, U.S. Pat. No. 5,397,339 (issued Mar. 14, 1995) describes a multipolar electrode catheter, which can be used to stimulate, ablate, obtain intercardiac signals, and can expand and enlarge itself inside the heart. Other applications include the ability to destroy plaque formations in the interior of lumens within the body; using RF energy applied near (or at the tip of) catheters such as described in U.S. Pat. No. 5,454,809 (issued Oct. 3, 1995) and U.S. Pat. No. 5,749,914 (issued May 12, 1998). In these applications a more advanced catheter (though similar to the EP catheters (described above)) contains an array of electrodes that is able to selectively apply energy in a specific direction. This device allows ablation and removal of asymmetric deposits/obstructions within lumens in the body. In that application, guidance may also be applied in various forms. U.S. Pat. No. 5,098,431 (issued Mar. 24, 1992), discloses another catheter based system for removing obstructions from within blood vessels. Parins in U.S. Pat. No. 5,078,717 (issued Jan. 7, 1992) discloses yet another catheter to selectively remove stenotic lesions from the interior walls of blood vessels. Auth in U.S. Pat. No. 5,364,393 (issued Nov. 15, 1994) describes a modification of the above technologies whereby a guide wire (a much smaller wire which goes through an angioplasty device and is typically 110 cm or longer) has an electrically energized tip, which creates a path to follow and thus guides itself through the obstructions.
In applications of a similar nature, catheters which carry larger busts of energy (for example from a defibrillator) into chambers of the heart have been disclosed. These catheters are used to destroy both tissues and structures as described in Cunningham (see U.S. Pat. No. 4,896,671 issued Jan. 30, 1990) that describes a catheter for delivery in electroshock ablative therapy.
One application of this technology would induce the elimination of glabellar furrowing by interrupting the conduction of nerve signals to muscles causing frown wrinkles. Traditional treatments have included surgical forehead lifts, resection of corrugator supercilli muscle, as described by Guyuron, Michelow and Thomas in Corrugator supercilli muscle resection through blepharoplasty incision., Plastic Reconstructive Surgery 95 691-696 (1995). Also, surgical division of the corrugator supercilli motor nerves is used and was described by Ellis and Bakala in Anatomy of the motor innervation of the corrugator supercilli muscle: clinical significance and development of a new surgical technique for frowning., J Otolaryngology 27; 222-227 (1998). These techniques described are highly invasive and sometimes temporary as nerves regenerate over time and repeat or alternative procedures are required.
More recently, a less invasive procedure to treat glabellar furrowing involves injection of botulinum toxin (Botox) directly into the muscle. This produces a flaccid paralysis and is best described in The New England Journal of Medicine, 324:1186-1194 (1991). While minimally invasive, this technique is predictably transient; so, it must be re-done every few months.
Specific efforts to use RF energy via a less sophisticated two needle bipolar system has been described in an articleby Hernandez-Zendejas and Guerrero-Santos called Percutaneous Selective Radio-Frequency Neuroablation in Plastic Surgery, Aesthetic Plastic Surgery, 18:41 pp 41-48 (1994) They described a bipolar system using two needle type electrodes. Utley and Goode described a similar system in Radio-frequency Ablation of the Nerve to the Corrugator Muscle for Elimination of Glabellar Furrowing, Archives of Facial Plastic Surgery, Jan-Mar, 99, VI P 46-48. Later they were granted U.S. Pat. No. 6,139,545 (issued Oct. 31, 2000), which fully described the two needle bipolar system. These systems were unable to produce permanent results (i.e. greater than a few months) because of limitations in the energy and their polar configurations and like with Botox, would have required periodic repeat procedures.
There are many ways of properly locating an active electrode near the target tissue and determining if it is in close proximity to the nerve. Traditional methods have included stimulation by using either unipolar and bipolar energy by means of a test pacemaker pulse prior to the implantation of a pacemaker or other stimulation device. A method of threshold analysis called the ‘strength duration curve’ has been used for many years. This curve consists of a vertical axis (or Y-axis) typically voltage, current, charge or other measure of amplitude, and has a horizontal axis (or X-axis) of pulse duration (typically in milliseconds). Such a curve is a rapidly declining line, which decreases exponentially as the pulse width is increased. This curve is described on pp31 ff in The Third Decade of Pacing, by Barold and Mugica (1982) and also on pp 245 in The Biomedical Engineering Handbook” CRC Press, IEEE Press, Ed by J. D. Bronzino, (1995).
Various stimulation devices have been made and patented. The process of stimulation/ablation using a two-needle system is disclosed in U.S. Pat. No. 6,139,545 (Oct. 31, 2000). This process is described in reverse, where the area not desired for detection of ancillary tissue is treated with stimulation then ablation. The process is best described in U.S. Pat. No. 5,782,826 (issued Jul. 21, 1998).
The new method and device of this preferred embodiment also uses (among other potential methods of locating the tip of the electrode in proximity to the target nerve) stimulation, followed by ablation. In this process the energy is delivered via the single puncture MIS system (as later described). This unique technology and resulting device is a single needle that contains both electrodes. It will access the site via a single puncture and will be used with MIS surgical techniques. It will also have features that provide for placement and have substantial added benefits, which are described later in this document.
The primary aspect, of the present invention, is to provide a single-needle type puncture entry way for bi-polar electrodes for delivering RF energy near the nerve (to terminate signal flow), in a minimally invasive procedure. Other aspects of this invention will be apparent from the appended claims, descriptions and drawings that follow.
Important aspects of this invention include:
A visible probe tip illumination to aide in positioning;
A hollow lumen for delivery of medication, often, but not limited to, anesthetic;
Delivery of ionizing radiation, via laser, to probe tip for direct energy delivery;
Coordination of ionizing radiation and RF energy delivery;
Unique probe identification;
Prior usage detection to eliminate potential contamination or unauthorized re use;
Procedure power settings matched to probe internal identification;
Direct reading of ablation probe temperature and impedance;
Pre-stored arbitrary amplitude modulation envelopes with multi-frequency for controlled energy delivery;
Controlled metered energy delivery determines permanence;
Multi-frequency operation for optimal power delivery;
Dynamic impedance matching for optimal power delivery;
Integrated dielectric insulator as fiber optic for illumination, thus reducing diameter;
Auxiliary nerve locator probe;
Depth markings on auxiliary probe;
Auxiliary probe needle shaft insulation;
Dual needle tipped auxiliary probe;
Electronic guidance of ablation probe to auxiliary probe;
Electronic guidance measures and displays current proportional probe distances;
Electronic guidance variable frequency audio tone proportional to distance/sense current;
Electronic guidance variable amplitude audio tone proportional to distance/sense current;
Electronic guidance variable frequency/flash rate of ablation tip illumination proportional to distance/sense current;
Illumination of florescent-tagged marker;
Detection of florescent emission of tagged marker;
Simultaneous illumination of florescent-tagged marker and emission detection;
Simultaneous illumination of florescent-tagged marker by means of a tunable laser;
Integrated hollow biopsy electrode for florescent-tagged tumor sampling;
Integrated hollow electrode for medication delivery to tagged tumor;
Integrated hollow electrode for photo-medication delivery to tagged tumor with illumination activation source; and
Another aspect of the invention is a probe usage register to reduce or eliminate chance of patient cross contamination.
This invention is an improved device (and method for its use) that will allow the physician to terminate signal flow through nerves, in a minimally invasive manner, by requiring only a single-needle type puncture. Said method and device would allow for a reduced patient recovery time; the patient would be awake during the procedure; using only a local (or very little) anesthetic; have a substantially reduced risk of infection; less of a risk of intensive care (or hospital stay), and subsequently, a reduced associated costs. Inasmuch, the patient would more rapidly return to a normal lifestyle as compared to many procedures requiring open surgery.
This single-puncture device (hereafter called ‘single-pass’) presents an improvement over conventional uni-polar systems because it does not require a separate return electrode, which is attached to the patient at a remote site and subsequently must be maintained during the surgical procedure. Also, it represents an improvement over bi-polar electrodes and earlier two needle systems, because it concentrates the energy specifically at the desired location (by use of one active electrode) and when ablation areas need to be precisely focused this device may best accomplish that task.
The device (and the methods needed to operate it) can be used to terminate, stop or inhibit (on a temporary, semi-permanent or even permanent basis) the transmission of nerve signals to the muscles, organs and receivers of nerve signals, which convey activation, perception, pain signals or other nervous impulses. In the preferred embodiment, the active electrode (or the probe/needle tip) may be positioned by various guidance and/or sensing means. This includes (but is not limited to) ultrasound, traditional pace/sense (apply stimulating signals and observe placement of the electrode in proximity to the target nerve), manual palpitation, proper anatomical positioning, X-ray, CT, MRI, PET or other radiation or emission type imaging means, fiber-optic video, external location (and marking) and subsequent location by illuminating the probe tip or by other similar means.
In addition to the ‘single-pass’ needle, the complete system shall include an intelligent external energy generator, which can be used either by programmed or manual control. The manual control may be mitigated (or limited for the protection of the patient) by means of various sensors including (but not limited to) impedance (and the change in impedance), temperature (and the change in temperature), normal voltage (or current) regulation, etc. Said generator will generate RF energy in the frequency range of 50 Khz to 2.5 Mhz, in a controlled manner.
The generator will also be usable under program control. Said programming will deliver a predetermined “bolus” (or packet) of electrical energy, whereby the dose is adjustable (within limits) by the physician proportional to the desired effect. This bolus will be predetermined in clinical studies and may have preset parameters such as minimal effect, average effect, maximum effect, corresponding to a low, normal and high-output level. The output cycle will be activated by the physician via footswitch, a button on the probe itself, voice or other similar method of activation methods. When the bolus output is activated it may be terminated (at any time) by releasing activation means (i.e. the footswitch, button or the like). However, it will provide output no greater or longer than the activation device is held down, and will also be limited to the length of time and dosage preset. To deliver a second packet of energy, the activation mechanism must be released for (an internally set) time period before another packet of energy may be delivered. Also, because this technology may be used in various applications (e.g. plastic surgery, spinal nerves causing back pain, and other applications where terminating signal flows through nerves is desired) the delivery systems (i.e. single-pass needle or probe, and the generator required to power same) may be of differing sizes, surface areas or mechanical configurations. Some may even require a substantially different amount or type of energy packet. Program setting and preferences made be controlled for the different applications by providing a specific hand tool device that would then contain a coded circuit, connector or other means of providing identification to the generator so that it may deliver the required energy packets automatically for the different applications or methods.
The methods of ablation may include both a linear or circular zone. The effective ablation area may be modified by “laying down” a series of individual ablation zones, thus creating a line of ablated tissues. This would be possible by withdrawing, inserting, and/or moving the active tip while ablating in the successive zones, which would expanding the liner component of any lesion produced. In the alternative, the effective zone of ablation could be extended circumferentially by manipulating the tip during the ablation cycle in small circles, thereby mechanically moving the tip enlarging the effective zone of ablation.
Defined below are the terms used here within:
The I2C bus is used on and between system boards for internal system management and diagnostic functions.
This section provides information on the overall operation of this system.
In normal operation, the novel probe 371 would combine a unique bipolar configuration in a single MIS needle, is inserted into the patient using MIS techniques. The probe, which may contain and/or convey various functions described later, is initially guided anatomically to the region of the anticipated or desired location. Various means of locating the tip 301 are utilized of placing the zone of ablation in the proper area to interrupt signal flows through the nerve 101.
This section refers to the drawings to describe use of the probe. There are many combinations of electrode diameters and tip shapes are possible. The ‘novel’ probe performs a variety of functions, such as stimulation, optical and electronic guidance, medication delivery, sample extraction, and controlled ablation. This bi-polar electrode is designed as a small diameter needle inserted from a single point of entry thus minimizing scaring and simplifying precise electrode placement. This low cost, compact design provides a new tool to the art.
Probes may emit fiber optic illumination for deep applications using electronic guidance as taught in
First the probe electrode 301 must be in the desired location relative to the target nerve 101 (
For example, both a high amplitude sine wave 910 (
The output of the modulator 415 is applied to the input of the power amplifier 416 section. The power amplifier's 416 outputs are then feed into the impedance matching network 418, which provides dynamic controlled output to the biologic loads that are highly variable and non-linear, and require dynamic control of both power levels and impedance matching. The tuning of the matching network 418 is performed for optimal power transfer for the probe, power level, and treatment frequencies settled. The system's peak power is 500 watts for this disclosed embodiment. Precise control is established by the proximity of the tip and the control loops included in the generator itself The final energy envelope 420 is delivered to probe tip 301 and return electrodes 302.
This precise control of energy permits extension of the ablation region(s), 140 and 1203 (
A low energy nerve stimulator 771 has been integrated into the system to assist in more precise identification of nearby structures and for highly accurate target location. Lastly, additional sensors, such as temperature 311, voltage, frequency, current and the like are read directly from the device and/or across the communications media 403 to the probe.
In addition to the substantial radially-symmetric ablation patterns with probes as taught in 371 (
The power amplifier output430 and buffered the feedback signals 437 are connected to an Analog to Digital converter (or ADC) 431 for processor analysis and control. Said signals 437 control power modulation 420 settings and impact the impedance matching control signals 419. This integrated power signal 437 is recorded to the operating-condition database (
At power startup, the controller 401(
The controller 401 also verifies selected procedure 1415 (
Nerve Target Location Tools
Prior to treatment, the practitioner may use auxiliary probe 771(
Location Via Florescence Marker Dye
In other procedures, whereby somewhat larger targets are sought, such as more diffuse nerve structures or small areas of abnormal growth (e.g. such as cancer) the injection of specially designed dyes that attach to target structures are used, as taught in
Electronic Probe Guidance
Low energy nerve stimulation current 810 (
Optical Probe Guidance
Disclosed invention provides optical sources 408 that aid in probe placement (
Data and Voice
Real-time engineering parameters are measured such as average power 437, luminous intensity 478, probe current 811, energy 438 and, temperature 330 to be recoded into USB memory 438. Simultaneously, the internal parameters disclosed such as frequency 423, modulation 420 and such are recoded into USB memory 438 as well. Additionally probe, patient, and procedure parameters (
At procedure conclusion, the system transfers the data 438 recorded to the USB removable memory 1338 and to a file server(s) 1309 and 1307. In the disclosed embodiment, data transfer is performed over Ethernet connection 480. Probe usage records 1460(
Before explaining the disclosed embodiment of the present invention in detail, it is to be understood that the invention is not limited in its application or to the details of the particular arrangement shown. The invention is capable of other embodiments. Further, the terminology used herein is for the purpose of describing the probe and its operation. Each apparatus embodiment described herein has numerous equivalents.
Bi-polar probe 310 represents probes 371, 372, 373 shown in FIGS. 3A-C with exception to type of needlepoint on the probe.
Hollow Electrode 301 often used as a syringe to deliver medication such as local anesthetic. Tip electrode 301 is connected to power amplifier 416 via impedance matching network 418 (
Ablation regions 306 and 140 extend radially about electrode 301 generally following electric field lines. For procedures very close to skin 330 a chance of burning exists in region 306. To minimize the chance of burning, a split return electrode probe 374 in
The bi-polar probe 380 (not drawn to scale) consists of an insulating dielectric body 309 made from a suitable biologically inert material, such as Teflon PTFE or other electrical insulation, that covers split return electrodes 302 and 303. The disclosed conductive return electrodes 302 and 303 are fabricated from medical grade stainless steel, titanium or other electrically conductive material. Hollow or solid split conductive tip electrodes 301 and 311 protrude from the surrounding dielectric insulator 305. The operation of the hollow/split conductive tip is very similar to probe tip 310 as taught in
Bi-polar probe 371 discloses conical shaped electrode 301 and tip 351 for minimally invasive single point entry. Probe diameter 358 is similar to a 20-gage or other small gauge syringe needle, but may be larger or smaller depending on the application, surface area required and depth of penetration necessary. In disclosed embodiment, electrode shaft 302 is 30 mm long with approximately 5 mm not insulated. Lengths and surface areas of both may be modified to meet various applications such as in cosmetic surgery or in elimination of back pain. The conductive return electrode 302 is fabricated from medical grade stainless steel, titanium or other conductive material. The dielectric insulator 305 in the disclosed embodiment is a transparent medical grade material such as polycarbonate, which may double as a light pipe or fiber optic cable. The high intensity light source 408 LED/laser (
The hollow chisel electrode 352 is often used as a syringe to deliver medication such as local anesthetic, medications,/tracer dye. The hollow electrode may also extract a sample. Dielectric insulator 305 in the disclosed embodiment is a transparent medical grade polycarbonate and performs as a light pipe or fiber optic cable. The novel dual-purpose dielectric reduces probe diameter and manufacturing costs. Light source 408, typically a LED or laser (
The bi-polar probe 373 discloses a tapered conical shaped probe for minimally invasive single point entry. It is constructed similarly to probe 371 as taught in
Description of this probe is described in both drawings 2A and 3D. Bi-polar probe 374 (not drawn to scale) consists of insulating dielectric body 309 made from a suitable biologically inert material, such as Teflon, that covers split return electrodes 302 and 303. Conductive return electrodes 302 are fabricated from medical grade stainless steel, titanium or other suitable conductive material. Hollow or solid split conductive tip electrodes 301 and 311 protrude from surrounding dielectric insulator 305. Their operation is very similar to probe tip 380 as taught in
Probe handle (not drawn to scale) encloses memory module 331, on/off switch 310 and mode switch 367. Temperature sensor 330 (located close to tip) monitors tissue temperature. Split electrode 380 (
Connections consist of a tapered dielectric sleeve 309 covering the ridged stainless electrode tube 302. Insulating sleeve 309 is made from a suitable biologically inert material, which covers electrode 302. Dielectric 305 insulates conical tipped electrodes 351 and 301.
See section Detailed Description of Device Operation.
Ablation probe 371 is inserted and directed anatomically into the area where the target nerve to be ablated (Box 531) is located. Test current 811 is applied (Box 532). If probe is located in the immediate proximity of the target nerve a physiological reaction will be detected/observed (Example: During elimination of glabellar furrowing, muscle stimulation of the forehead will be observed). If reaction is observed, then a mark may optionally be applied on the surface of the skin to locate the area of the nerve. Power is applied (Box 535) in an attempt to ablate the nerve. If physiological reaction is not observed, (Box 534) the probe will be relocated closer to the target nerve and the stimulation test will be repeated (Box 536 & 537). If no physiological reaction is observed, the procedure may be terminated (Box 544). Also, the probe may be moved in any direction, up, down, near, far, circular, in a pattern, etc. to create a larger area of ablation for a more permanent result.
In Box 537, if stimulation is observed again, then the ablation power may be set higher (Box 538), alternatively, as mentioned, the needle may be moved in various directions, or a larger dosage of energy may be reapplied, to form a larger area of ablation for more effective or permanent termination of signal conduction through the nerve. After delivery of power (Box 540), stimulation energy may be applied again (Box 541). If there is no stimulation, the procedure is completed (Box 544). If there is still signal flow through the nerve (stimulation or physiological reaction) then the probe may be relocated (Box 542) and the procedure is started over again (Box 533).
Auxiliary probes 771 and 772 (
Operation 530 (
Between each ablation, procedure 540 (
As an example and not a limitation, five ablation regions (140, 141, 142, 143, and 144) are shown in
Probe insertion and placement is same as taught in
In special cases were target nerve 101 or ablation region 640 is in close proximity to second nerve 111 or skin 330 bi-polar probes 371 or 372 (
Probe construction is similar to
This probe may be used in conjunction with any of the therapeutic probes 371 and their derivatives. The needle itself will be very fine in nature, such as an acupuncture type needle. By its small size, numerous needle insertions may be accomplished with no scarring and minimal pain. The probe 771 will be inserted in the vicinity of the target tissue through skin 330. The exposed tip of 771, 702 will be exposed and electrically connected to generator 732 via wire 734. The surface of probe 771 is covered with dielectric 704 so the only exposed electrical contact is surface 702 and return electrode 736. Exposed tip 702 will be advanced to the vicinity of target 101 and test stimulation current will be applied. Appropriate physiological reaction will be observed and when the tip 702 is properly located, depth will be noted via observing marks 765. External mark 755 may be applied for reference. Ablation probe 371 may then be advanced to the proximity of the target tissue under the X mark 755 and ablation/nerve destruction as described elsewhere may be performed.
Dual tipped probe 772 offers an additional embodiment that eliminates return electrode pad 736. Probe frame/handle 739 holds two fine needles, 702 and 701, in the disclosed embodiment that are spaced a short distance (a few mm)-mm apart (730). The shaft of conductive needle 701 is covered with dielectric insulator 706, similar to the construction of probe 771 (
Probes 702 and 701 are very small gage needles similar in size to common acupuncture needles, thus permitting repeated probing with minimal discomfort, bleeding, and insertion force. Sharp probes are inserted thru skin 330 and muscle layer(s) 710 near nerve 101. The practitioner locates target nerve 101, then the skin surface may be marked 755 as location aide for ablation step as shown in flow chart (
Auxiliary probes 771 and 772 (
Auxiliary probe 771 and 772 provide a method to quickly locate shallow or deep target structures. Shallow structures are typically marked with ink pen allowing illuminated ablation probe 371 or its equivalents to be quickly guided to mark 755. Optionally, non-illuminated probes may be used by the practitioner who simply feels for the probe tip. For deep structures, probe 771 may also be employed as an electronic beacon; small current 811 (which will be lower intensity and different from the stimulating current) from probe tip 702 is used to guide ablation probe 372. Amplifier 430 (
Lower energy pulse width modulated (or PWM) sinusoid 920 for coagulation is also well known to electro-surgery art. Variations of cut followed by coagulation are also well known.
Auxiliary probes 771 and 772 (
Ablation probe 372 is inserted thru skin 330 and muscle layer(s) 710 near nerve 101. Illumination source 408 permits practitioner to quickly and accuracy guide illuminated 448 ablation probe 372 into position. Illumination 448 from ablation probe as seen by practitioner 775 is used as an additional aide in depth estimation. Selectable nerve simulation current 811 aids nerve 101 location within region 1204. This novel probe placement system gives practitioner confidence system is working correctly so s/he can concentrate on the delicate procedure. Accurate probe location permits use of minimal energy during ablation, minimizing damage to non-target structures and reducing healing time and patient discomfort.
Region 1203 shows the general shape of the ablation region for conical tip 301. Tip 301 is positioned in close proximity to target nerve 101. Ablation generally requires one or a series of localized ablations. Number and ablation intensity/energy are set by the particular procedure and the desired permanence.
Five ablation regions are illustrated 140, 141, 142, 143, and 144; however, there could be more or less regions. Ablation starts with area 144, then the probe is moved to 143 and so on to 140, conversely, ablations could start at 140 and progress to 144. Also, the practitioner could perform rotating motions, thus further increasing the areas of ablation and permanence of the procedure. Between each ablation procedure 540 (
Controller 101 maintains local probe 1460, patient 1430, and procedure 1410 databases. All work together to insure correct probes and settings are used for the desired procedure. Automatically verifying that the attached probe matches selected procedure and verifying probe authentication and usage to avoid patient cross contamination or use of unauthorized probes. Automatic probe inventory control quickly and accurately transfers procedure results to the billing system.
From a touch screen, the practitioner selects the desired procedure from list 1410. For example “TEMPORARY NERVE CONDUCTION” 1411, “SMALL TUMOR 1CC” 1412, and “SMALL NERVE ABLATE” 1413 are a few of the choices. Each procedure has a unique procedure code 1416 to be used in the billing system. Power range parameter 1417 is a recommended power setting via power level control 404. The recommended probe(s) Associated with procedure 1415 and power range parameter 1417 are listed in parameters 1419. With the probe connected, the part number is read from memory 331 (
From touch screen 450 (
During the procedure (
Use of a USB memory stick permits continued operation in the event of a network 1326 failure Data is loaded to memory 1338 for simple transfer to office computer 1306 (
If computer network 1326 such as Ethernet 802.11 or wireless 802.11x is available, files are mirrored to local storage 1309, remote server 1307. The remote server (typically maintained by equipment manufacture) can be remotely update procedure(s). To insure data integrity and system reliability a high availability database engine made by Birdstep of Americas Birdstep technology, Inc 2101 Fourth Ave. Suite 2000, Seattle Wash. is offered as an example. The Birdstep database supports distributed backups, extensive fault and error recovery while requiring minimal system resources.
From a touch screen, the practitioner selects or enters patient name from previous procedure 1430 and creates a new record 1433. Similarly, a procedure is selected from 1410 (for example “TEMPORARY NERVE CONDUCTION” 1411, “SMALL TUMOR 1CC” 1412, and “SMALL NERVE ABLATE” 1413). Each procedure has a unique procedure code 1416 that is used for the billing system. Other information such as practitioners name 1440, date 1435 is entered to record 1433. As taught above probe appropriate for the procedure is connected and verified, part 1470 and serial number 1469 recorded.
The practitioner enters additional text notes to file 1442 or records them with microphone 455 (
At the end of procedure, records are updated and stored to memory 438. Backup copies are written to USB 1320 memory stick 1338 (
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3104879 *||5 Jul 1961||24 Sep 1963||Jetton|
|US4411266 *||24 Sep 1980||25 Oct 1983||Cosman Eric R||Thermocouple radio frequency lesion electrode|
|US4674499 *||10 Ene 1985||23 Jun 1987||Pao David S C||Coaxial bipolar probe|
|US4896671 *||1 Ago 1988||30 Ene 1990||C. R. Bard, Inc.||Catheter with contoured ablation electrode|
|US4936842 *||22 Feb 1989||26 Jun 1990||Circon Corporation||Electrosurgical probe apparatus|
|US5078717 *||10 Sep 1990||7 Ene 1992||Everest Medical Corporation||Ablation catheter with selectively deployable electrodes|
|US5098431 *||3 Jul 1990||24 Mar 1992||Everest Medical Corporation||RF ablation catheter|
|US5122137 *||27 Abr 1990||16 Jun 1992||Boston Scientific Corporation||Temperature controlled rf coagulation|
|US5364393 *||30 Dic 1993||15 Nov 1994||Heart Technology, Inc.||Tissue dissipative recanalization catheter|
|US5397339 *||7 May 1993||14 Mar 1995||Desai; Jawahar M.||Catheter for mapping and ablation and method therefor|
|US5439224 *||13 Oct 1993||8 Ago 1995||Bertoncino; James||Driving range with automated scoring system|
|US5450846 *||5 Ene 1994||19 Sep 1995||Goldreyer; Bruce N.||Method for spatially specific electrophysiological sensing for mapping, pacing and ablating human myocardium and a catheter for the same|
|US5454809 *||19 Abr 1994||3 Oct 1995||Angioplasty Systems, Inc.||Electrosurgical catheter and method for resolving atherosclerotic plaque by radio frequency sparking|
|US5458597 *||8 Nov 1993||17 Oct 1995||Zomed International||Device for treating cancer and non-malignant tumors and methods|
|US5540681 *||10 Ene 1994||30 Jul 1996||Medtronic Cardiorhythm||Method and system for radiofrequency ablation of tissue|
|US5674191 *||18 Ago 1995||7 Oct 1997||Somnus Medical Technologies, Inc.||Ablation apparatus and system for removal of soft palate tissue|
|US5697536 *||18 Nov 1996||16 Dic 1997||Arthrocare Corporation||System and method for electrosurgical cutting and ablation|
|US5697882 *||22 Nov 1995||16 Dic 1997||Arthrocare Corporation||System and method for electrosurgical cutting and ablation|
|US5697909 *||10 May 1994||16 Dic 1997||Arthrocare Corporation||Methods and apparatus for surgical cutting|
|US5749914 *||28 May 1996||12 May 1998||Advanced Coronary Intervention||Catheter for obstructed stent|
|US5782826 *||1 Nov 1996||21 Jul 1998||Ep Technologies, Inc.||System and methods for detecting ancillary tissue near tissue targeted for ablation|
|US5843019 *||18 Jul 1996||1 Dic 1998||Arthrocare Corporation||Shaped electrodes and methods for electrosurgical cutting and ablation|
|US5895386 *||20 Dic 1996||20 Abr 1999||Electroscope, Inc.||Bipolar coagulation apparatus and method for arthroscopy|
|US5897552 *||4 Sep 1997||27 Abr 1999||Ep Technologies, Inc.||Electrode and associated systems using thermally insulated temperature sensing elements|
|US5906614 *||18 Feb 1997||25 May 1999||Ep Technologies, Inc.||Tissue heating and ablation systems and methods using predicted temperature for monitoring and control|
|US5971983 *||9 May 1997||26 Oct 1999||The Regents Of The University Of California||Tissue ablation device and method of use|
|US6004319 *||20 Jun 1996||21 Dic 1999||Gyrus Medical Limited||Electrosurgical instrument|
|US6016452 *||19 Mar 1997||18 Ene 2000||Kasevich; Raymond S.||Dynamic heating method and radio frequency thermal treatment|
|US6023638 *||22 May 1998||8 Feb 2000||Scimed Life Systems, Inc.||System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue|
|US6096035 *||27 Feb 1998||1 Ago 2000||Sodhi; Chris||Multipolar transmural probe|
|US6102907 *||15 Ago 1997||15 Ago 2000||Somnus Medical Technologies, Inc.||Apparatus and device for use therein and method for ablation of tissue|
|US6122549 *||24 Jun 1997||19 Sep 2000||Oratec Interventions, Inc.||Apparatus for treating intervertebral discs with resistive energy|
|US6139545 *||9 Sep 1998||31 Oct 2000||Vidaderm||Systems and methods for ablating discrete motor nerve regions|
|US6146380 *||9 Ene 1998||14 Nov 2000||Radionics, Inc.||Bent tip electrical surgical probe|
|US6149620 *||12 Feb 1999||21 Nov 2000||Arthrocare Corporation||System and methods for electrosurgical tissue treatment in the presence of electrically conductive fluid|
|US6149647 *||19 Abr 1999||21 Nov 2000||Tu; Lily Chen||Apparatus and methods for tissue treatment|
|US6159194 *||2 Oct 1997||12 Dic 2000||Arthrocare Corporation||System and method for electrosurgical tissue contraction|
|US6161048 *||26 Jun 1997||12 Dic 2000||Radionics, Inc.||Method and system for neural tissue modification|
|US6165169 *||15 Abr 1999||26 Dic 2000||Ep Technologies, Inc.||Systems and methods for identifying the physical, mechanical, and functional attributes of multiple electrode arrays|
|US6197021 *||17 Sep 1998||6 Mar 2001||Ep Technologies, Inc.||Systems and methods for controlling tissue ablation using multiple temperature sensing elements|
|US6241753 *||5 Ene 1996||5 Jun 2001||Thermage, Inc.||Method for scar collagen formation and contraction|
|US6246912 *||19 Jul 1999||12 Jun 2001||Sherwood Services Ag||Modulated high frequency tissue modification|
|US6259945 *||30 Abr 1999||10 Jul 2001||Uromed Corporation||Method and device for locating a nerve|
|US6259952 *||1 Oct 1999||10 Jul 2001||Radionics, Inc.||Method and apparatus for altering neural tissue function|
|US6292695 *||17 Jun 1999||18 Sep 2001||Wilton W. Webster, Jr.||Method and apparatus for transvascular treatment of tachycardia and fibrillation|
|US6312428 *||12 Jul 1999||6 Nov 2001||Neothermia Corporation||Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue|
|US6337994 *||27 Abr 1999||8 Ene 2002||Johns Hopkins University||Surgical needle probe for electrical impedance measurements|
|US6379349 *||7 Nov 1996||30 Abr 2002||Celon Ag Medical Instruments||Arrangement for electrothermal treatment of the human or animal body|
|US6381498 *||6 Ene 1998||30 Abr 2002||Thermage, Inc.||Method and apparatus for controlled contraction of collagen tissue|
|US6384384 *||28 Jul 2000||7 May 2002||General Electric Company||Boil dry detection in cooking appliances|
|US6405732 *||1 Oct 1999||18 Jun 2002||Curon Medical, Inc.||Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors|
|US6466817 *||8 Jun 2000||15 Oct 2002||Nuvasive, Inc.||Nerve proximity and status detection system and method|
|US6524308 *||4 Sep 1998||25 Feb 2003||Celon Ag Medical Instruments||Electrode arrangement for electrothermal treatment of human or animal bodies|
|US6569028 *||28 Ene 2000||27 May 2003||Glowrange, L.L.C.||Golf driving range|
|US6575969 *||21 Ago 2000||10 Jun 2003||Sherwood Services Ag||Cool-tip radiofrequency thermosurgery electrode system for tumor ablation|
|US6618626 *||29 Ago 2001||9 Sep 2003||Hs West Investments, Llc||Apparatus and methods for protecting the axillary nerve during thermal capsullorhaphy|
|US6663627 *||24 Abr 2002||16 Dic 2003||Medtronic, Inc.||Ablation system and method of use|
|US6719754 *||10 Abr 2002||13 Abr 2004||Arthrocare Corporation||Methods for electrosurgical-assisted lipectomy|
|US6740084 *||18 Dic 2001||25 May 2004||Ethicon, Inc.||Method and device to enhance RF electrode performance|
|US6749604 *||30 Mar 2000||15 Jun 2004||Arthrocare Corporation||Electrosurgical instrument with axially-spaced electrodes|
|US6911027 *||29 Abr 1999||28 Jun 2005||Somnus Medical Technologies, Inc.||Device for the ablation of tissue|
|US6989010 *||11 Feb 2003||24 Ene 2006||Medtronic, Inc.||Ablation system and method of use|
|US7115124 *||25 Oct 2004||3 Oct 2006||Jia Hua Xiao||Device and method for tissue ablation using bipolar radio-frequency current|
|US7177677 *||16 Oct 2002||13 Feb 2007||Nuvasive, Inc.||Nerve proximity and status detection system and method|
|US7282049 *||3 Oct 2005||16 Oct 2007||Sherwood Services Ag||Electrosurgical system employing multiple electrodes and method thereof|
|US7300435 *||21 Nov 2003||27 Nov 2007||Sherwood Services Ag||Automatic control system for an electrosurgical generator|
|US20020065481 *||21 Nov 2001||30 May 2002||Ckm Diagnostics, Inc.||Nerve stimulator output control needle with depth determination capability and method of use|
|US20020065567 *||6 Nov 2001||30 May 2002||Kodera Electronics Co., Ltd.||Game providing system in golf driving range|
|US20020120260 *||28 Feb 2001||29 Ago 2002||Morris David L.||Tissue surface treatment apparatus and method|
|US20050033137 *||14 Jun 2004||10 Feb 2005||The Regents Of The University Of Michigan||Ablation catheters and methods for their use|
|US20050177211 *||14 Abr 2005||11 Ago 2005||Baylis Medical Company Inc.||Electrosurgical device for treatment of tissue|
|US20050283148 *||17 Jun 2004||22 Dic 2005||Janssen William M||Ablation apparatus and system to limit nerve conduction|
|US20060089688 *||25 Oct 2004||27 Abr 2006||Dorin Panescu||Method and apparatus to reduce wrinkles through application of radio frequency energy to nerves|
|US20080051859 *||30 Oct 2007||28 Feb 2008||Oratec Interventions, Inc.||Method for treating intervertebral discs|
|USRE40279 *||26 Jun 1997||29 Abr 2008||Sherwood Services Ag||Method and system for neural tissue modification|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US7645277||22 Dic 2005||12 Ene 2010||Salient Surgical Technologies, Inc.||Fluid-assisted medical device|
|US7651494||29 Ene 2003||26 Ene 2010||Salient Surgical Technologies, Inc.||Fluid-assisted medical device|
|US7713266||5 Dic 2005||11 May 2010||Myoscience, Inc.||Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)|
|US7727232||4 Feb 2005||1 Jun 2010||Salient Surgical Technologies, Inc.||Fluid-assisted medical devices and methods|
|US7738968||15 Oct 2005||15 Jun 2010||Baxano, Inc.||Devices and methods for selective surgical removal of tissue|
|US7738969||21 Ene 2009||15 Jun 2010||Baxano, Inc.||Devices and methods for selective surgical removal of tissue|
|US7740631||15 Oct 2005||22 Jun 2010||Baxano, Inc.||Devices and methods for tissue modification|
|US7799021 *||4 Ago 2005||21 Sep 2010||Kimberly-Clark Inc.||Electrosurgical treatment in conjunction with monitoring|
|US7811282||14 Nov 2005||12 Oct 2010||Salient Surgical Technologies, Inc.||Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof|
|US7815634||22 Dic 2003||19 Oct 2010||Salient Surgical Technologies, Inc.||Fluid delivery system and controller for electrosurgical devices|
|US7850683||28 Jun 2007||14 Dic 2010||Myoscience, Inc.||Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)|
|US7857813||29 Ago 2006||28 Dic 2010||Baxano, Inc.||Tissue access guidewire system and method|
|US7862558||6 Mar 2009||4 Ene 2011||Myoscience, Inc.||Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)|
|US7887538||13 Mar 2006||15 Feb 2011||Baxano, Inc.||Methods and apparatus for tissue modification|
|US7938830||17 Abr 2006||10 May 2011||Baxano, Inc.||Powered tissue modification devices and methods|
|US7949402||21 Dic 2006||24 May 2011||Neuropoint Medical, Inc.||Neuro-stimulation and ablation system|
|US7951148||6 Feb 2004||31 May 2011||Salient Surgical Technologies, Inc.||Electrosurgical device having a tissue reduction sensor|
|US8206381||17 Ene 2007||26 Jun 2012||Endymed Medical Ltd.||Electrosurgical methods and devices employing phase-controlled radiofrequency energy|
|US8298216||14 Nov 2008||30 Oct 2012||Myoscience, Inc.||Pain management using cryogenic remodeling|
|US8366712||6 Dic 2011||5 Feb 2013||Baxano, Inc.||Multiple pathways for spinal nerve root decompression from a single access point|
|US8409185||16 Feb 2007||2 Abr 2013||Myoscience, Inc.||Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling|
|US8414571||9 Abr 2013||Relievant Medsystems, Inc.||Vertebral bone navigation systems|
|US8425507 *||12 Sep 2012||23 Abr 2013||Relievant Medsystems, Inc.||Basivertebral nerve denervation|
|US8512331||14 Jun 2012||20 Ago 2013||Endymed Medical Ltd.||Electrosurgical methods and devices employing phase-controlled radiofrequency energy|
|US8535309||6 Jul 2012||17 Sep 2013||Relievant Medsystems, Inc.||Vertebral bone channeling systems|
|US8728071||27 Feb 2013||20 May 2014||Endymed Medical Ltd.||Systems and methods employing radiofrequency energy for skin treatment|
|US8784415 *||5 May 2009||22 Jul 2014||Stryker Corporation||Powered surgical tool with an isolation circuit connected between the tool power terminals and the memory internal to the tool|
|US8808284||26 Ago 2010||19 Ago 2014||Relievant Medsystems, Inc.||Systems for navigating an instrument through bone|
|US8810805 *||1 Feb 2013||19 Ago 2014||Sick Ag||Light source for a sensor and a distance-measuring optoelectronic sensor|
|US8968297 *||19 Jul 2011||3 Mar 2015||Covidien Lp||Microwave and RF ablation system and related method for dynamic impedance matching|
|US9005100||14 Dic 2012||14 Abr 2015||The Board Of Trustees Of The Leland Stanford Jr. University||Apparatus and methods for treating pulmonary hypertension|
|US9028391||4 Abr 2014||12 May 2015||The Board Of Trustees Of The Leland Stanford Jr. University||Apparatus and methods for treating pulmonary hypertension|
|US9028482 *||19 Jul 2011||12 May 2015||Covidien Lp||Microwave and RF ablation system and related method for dynamic impedance matching|
|US9031667 *||6 Mar 2006||12 May 2015||InterventionTechnology Pty Ltd||Minimal device and method for effecting hyperthermia derived anesthesia|
|US9039701||9 Ago 2013||26 May 2015||Relievant Medsystems, Inc.||Channeling paths into bone|
|US9066712||22 Dic 2009||30 Jun 2015||Myoscience, Inc.||Integrated cryosurgical system with refrigerant and electrical power source|
|US9066720||25 Oct 2011||30 Jun 2015||Medtronic Ardian Luxembourg S.A.R.L.||Devices, systems and methods for evaluation and feedback of neuromodulation treatment|
|US9072498||17 Nov 2010||7 Jul 2015||Myoscience, Inc.||Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)|
|US9101346||30 Sep 2013||11 Ago 2015||Myoscience, Inc.||Pain management using cryogenic remodeling|
|US9101386||25 Oct 2010||11 Ago 2015||Amendia, Inc.||Devices and methods for treating tissue|
|US20050283148 *||17 Jun 2004||22 Dic 2005||Janssen William M||Ablation apparatus and system to limit nerve conduction|
|US20060030845 *||4 Ago 2005||9 Feb 2006||Baylis Medical Company, Inc.||Electrosurgical treatment in conjunction with monitoring|
|US20090275940 *||5 Nov 2009||Malackowski Donald W||Surgical tool system including a tool and a control console, the console capable of reading data from a memory internal to the tool over the conductors over which power is sourced to the tool|
|US20100152715 *||21 Feb 2010||17 Jun 2010||Pattanam Srinivasan||Method for Deep Tissue Laser Treatments Using Low Intensity Laser Therapy Causing Selective Destruction of Nociceptive Nerves|
|US20110104632 *||10 May 2010||5 May 2011||Colby Leigh E||Therapeutic tooth ablation|
|US20110200960 *||18 Ago 2011||Colby Leigh E||Therapeutic tooth bud ablation|
|US20120330300 *||6 Jul 2012||27 Dic 2012||Relievant Medsystems, Inc.||Intraosseous nerve denervation methods|
|US20130006233 *||3 Ene 2013||Relievant Medsystems, Inc.||Basivertebral nerve denervation|
|US20130023870 *||24 Ene 2013||Tyco Healthcare Group Lp||Microwave and rf ablation system and related method for dynamic impedance matching|
|US20130023871 *||24 Ene 2013||Tyco Healthcare Group Lp||Microwave and rf ablation system and related method for dynamic impedance matching|
|US20130229668 *||1 Feb 2013||5 Sep 2013||Sick Ag||Light source for a sensor and a distance-measuring optoelectronic sensor|
|US20140051999 *||25 Oct 2013||20 Feb 2014||Nuvasive, Inc.||System and Methods for Nerve Monitoring|
|EP2068740A4 *||27 Jul 2007||25 Feb 2015||Serene Medical Inc||Ablation apparatus and system to limit nerve conduction|
|WO2009124726A1 *||7 Abr 2009||15 Oct 2009||Erbe Elektromedizin Gmbh||Surgical apparatus comprising a nerve testing device|
|WO2011136962A1 *||18 Abr 2011||3 Nov 2011||Medtronic Xomed, Inc.||Interface module for use with nerve monitoring and electrosurgery|
|WO2012078278A1 *||7 Nov 2011||14 Jun 2012||Salient Surgical Technologies, Inc.||Bipolar electrosurgical device|
|WO2013163307A2 *||24 Abr 2013||31 Oct 2013||Medtronic Xomed, Inc.||Stimulation probe for robotic and laparoscopic surgery|
|WO2015038167A1 *||16 Sep 2013||19 Mar 2015||Empire Technology Development, Llc||Nerve location detection|
|Clasificación de EE.UU.||606/34, 606/48, 606/50|
|Clasificación internacional||A61B19/00, A61B18/14|
|Clasificación cooperativa||A61B2019/4873, A61B18/1477, A61B2019/4815, A61B2017/00482, A61B2019/5437, A61B19/5202, A61B2018/00434, A61B2018/00988, A61B19/5244|
|14 Jun 2005||AS||Assignment|
Owner name: JNJ TECHNOLOGY HOLDINGS, L.L.C., COLORADO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JANSSEN, WILLIAM MICHAEL;NEWMAN, JAMES PAUL;JONES, JAMESWHITNEY;AND OTHERS;REEL/FRAME:016333/0732;SIGNING DATES FROM 20050607 TO 20050610
|2 Sep 2008||AS||Assignment|
Owner name: BIOFORM MEDICAL, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JNJ TECHNOLOGY HOLDINGS, LLC;REEL/FRAME:021468/0066
Effective date: 20080424
|27 Ene 2012||AS||Assignment|
Owner name: SERENE MEDICAL, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOFORM MEDICAL, INC.;REEL/FRAME:027611/0726
Effective date: 20110907